Variability of cost trajectories over the last year of life in patients with advanced breast cancer in the Netherlands

Abstract

The average costs of advanced breast cancer patients increased towards the end of life. However, we uncovered several latent groups of patients with divergent cost trajectories, which did not reflect the overall increasing trend. The mechanisms underlying the variability in cost trajectories warrants further research.